Chengxin Zhang1, Wenhui Gong2, Haiyuan Liu3, Zhixiang Guo1, Shenglin Ge1. 1. Department of Cardiovascular Surgery, The First Affiliated Hospital of Anhui Medical University 218 Jixi Road, Hefei 230022, Anhui, China. 2. Department of Cardiovascular Surgery, Ruijing Hospital, Shanghai Jiaotong University School of Medicine 197 Ruijin Er Road, Shanghai 200025, China. 3. Department of Oncology, The Hefei Hospital Affiliated with Anhui Medical University Langxi Road, Yaohai District, Hefei 230000, Anhui Province, China.
Abstract
OBJECTIVE: This study aims to demonstrate the protective effect of doxycycline, an exogenous inhibitor of matrix metalloproteinases-9 (MMP-9), in the acute lung injury induced by cardiopulmonary bypass (CPB). METHODS: A total of 30 healthy mongrel dogs were randomly divided into three groups: Group A (CPB control group, no treatment of doxycycline), Group B (low-dose group, treated with doxycycline at 30 mg/kg) and Group C (high-dose group, doxycycline at 60 mg/kg). The alveolar-arterial oxygen difference (A-aDO2) and respiratory index (RI) were calculated, the concentration of MMP-9 in plasma was measured by ELISA. The expression levels of MMP-9 was determined by RT-PCR. The lung W/D index was calculated. The myeloperoxidase (MPO) activity of bronchoalveolar lavage fluid (BALF) was measured by colorimetry. The total protein of BALF was measured by Coomassie brilliant blue G-250. The white blood count (WBC) in the sediment of BALF was counted. RESULTS: A-aDO2, RI, total protein, and MPO activity of BALF, WBC count in BALF sediment and W/D index in group B were significantly lower than that of control group (P < 0.05). The concentration of MMP-9 in group C decreased significantly (P < 0.05). There were no significant differences in gene expression among the three groups. CONCLUSION: The results suggested that doxycycline protected the acute lung injury induced by CPB through reducing the concentration of MMP-9 and degradation of the cell membrane, pulmonary neutrophil infiltration and pulmonary edema.
OBJECTIVE: This study aims to demonstrate the protective effect of doxycycline, an exogenous inhibitor of matrix metalloproteinases-9 (MMP-9), in the acute lung injury induced by cardiopulmonary bypass (CPB). METHODS: A total of 30 healthy mongrel dogs were randomly divided into three groups: Group A (CPB control group, no treatment of doxycycline), Group B (low-dose group, treated with doxycycline at 30 mg/kg) and Group C (high-dose group, doxycycline at 60 mg/kg). The alveolar-arterial oxygen difference (A-aDO2) and respiratory index (RI) were calculated, the concentration of MMP-9 in plasma was measured by ELISA. The expression levels of MMP-9 was determined by RT-PCR. The lung W/D index was calculated. The myeloperoxidase (MPO) activity of bronchoalveolar lavage fluid (BALF) was measured by colorimetry. The total protein of BALF was measured by Coomassie brilliant blue G-250. The white blood count (WBC) in the sediment of BALF was counted. RESULTS: A-aDO2, RI, total protein, and MPO activity of BALF, WBC count in BALF sediment and W/D index in group B were significantly lower than that of control group (P < 0.05). The concentration of MMP-9 in group C decreased significantly (P < 0.05). There were no significant differences in gene expression among the three groups. CONCLUSION: The results suggested that doxycycline protected the acute lung injury induced by CPB through reducing the concentration of MMP-9 and degradation of the cell membrane, pulmonary neutrophil infiltration and pulmonary edema.
Authors: J Cremer; M Martin; H Redl; S Bahrami; C Abraham; T Graeter; A Haverich; G Schlag; H G Borst Journal: Ann Thorac Surg Date: 1996-06 Impact factor: 4.330
Authors: T S Gipson; N M Bless; T P Shanley; L D Crouch; M R Bleavins; E M Younkin; V Sarma; D F Gibbs; W Tefera; P C McConnell; W T Mueller; K J Johnson; P A Ward Journal: J Immunol Date: 1999-03-15 Impact factor: 5.422
Authors: D E Carney; C J Lutz; A L Picone; L A Gatto; N S Ramamurthy; L M Golub; S R Simon; B Searles; A Paskanik; K Snyder; C Finck; H J Schiller; G F Nieman Journal: Circulation Date: 1999-07-27 Impact factor: 29.690
Authors: Adrian Doroszko; Thomas S Hurst; Dorota Polewicz; Jolanta Sawicka; Justyna Fert-Bober; David H Johnson; Grzegorz Sawicki Journal: Proteome Sci Date: 2010-01-29 Impact factor: 2.480
Authors: Guillermo M Albaiceta; Ana Gutiérrez-Fernández; Diego Parra; Aurora Astudillo; Emilio García-Prieto; Francisco Taboada; Antonio Fueyo Journal: Am J Physiol Lung Cell Mol Physiol Date: 2008-01-25 Impact factor: 5.464
Authors: Estefania Ugarte-Berzal; Lise Boon; Erik Martens; Vasily Rybakin; Daniel Blockmans; Jennifer Vandooren; Paul Proost; Ghislain Opdenakker Journal: Front Immunol Date: 2019-03-22 Impact factor: 7.561